[HTML][HTML] Pre-clinical investigation of STAT3 pathway in bladder cancer: paving the way for clinical translation
S Mirzaei, MH Gholami, MK Mahabady… - Biomedicine & …, 2021 - Elsevier
Effective cancer therapy requires identification of signaling networks and investigating their
potential role in proliferation and invasion of cancer cells. Among molecular pathways …
potential role in proliferation and invasion of cancer cells. Among molecular pathways …
Machine learning in prediction of bladder cancer on clinical laboratory data
IJ Tsai, WC Shen, CL Lee, HD Wang, CY Lin - Diagnostics, 2022 - mdpi.com
Bladder cancer has been increasing globally. Urinary cytology is considered a major
screening method for bladder cancer, but it has poor sensitivity. This study aimed to utilize …
screening method for bladder cancer, but it has poor sensitivity. This study aimed to utilize …
[PDF][PDF] Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: a meta-analysis.
Q Wang, SR Zhu, XP Huang, XQ Liu… - European Review for …, 2021 - europeanreview.org
OBJECTIVE: The systemic immune-inflammation index (SII), an inexpensive and widely
available hematologic marker of inflammation, has been linked to tumor progression …
available hematologic marker of inflammation, has been linked to tumor progression …
Tea consumption and risk of bladder cancer in the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) Study: Pooled analysis of 12 international …
Background & aims Tea has been shown to be associated with reduced risk of several
diseases including cardiovascular diseases, stroke, metabolic syndrome, and obesity …
diseases including cardiovascular diseases, stroke, metabolic syndrome, and obesity …
E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies
M Wang, Z Zhang, Z Li, Y Zhu, C Xu - Frontiers in Immunology, 2023 - frontiersin.org
With the rapidly increasing incidence of bladder cancer in China and worldwide, great efforts
have been made to understand the detailed mechanism of bladder cancer tumorigenesis …
have been made to understand the detailed mechanism of bladder cancer tumorigenesis …
The epidemiology of bladder cancer
M Mossanen - Hematology/Oncology Clinics, 2021 - hemonc.theclinics.com
The Epidemiology of Bladder Cancer - Hematology/Oncology Clinics Skip to Main Content Skip
to Main Menu Advertisement Hematology/Oncology Clinics Log in Register Log in Subscribe …
to Main Menu Advertisement Hematology/Oncology Clinics Log in Register Log in Subscribe …
Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer
S Bazargan, B Bunch, AME Ojwang '… - Frontiers in …, 2023 - frontiersin.org
Background New therapeutics in development for bladder cancer need to address the
recalcitrant nature of the disease. Intravesical adoptive cell therapy (ACT) with tumor …
recalcitrant nature of the disease. Intravesical adoptive cell therapy (ACT) with tumor …
Advances in AI‐based cancer cytopathology
Y Yang, S Guan, Z Ou, W Li, L Yan… - Interdisciplinary …, 2023 - Wiley Online Library
Cytopathological examination plays a crucial role in cancer diagnosis as it reflects the
cellular pathology of cancer. However, this process traditionally relies on the visual …
cellular pathology of cancer. However, this process traditionally relies on the visual …
[HTML][HTML] Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways
YR Chen, SC Wang, SP Huang, CC Su, PL Liu… - Biomedicine & …, 2022 - Elsevier
Bladder cancer is one of the most common malignancies of the male genitourinary urinary
system. Protodioscin is a steroidal saponin with anti-cancer effects on several types of …
system. Protodioscin is a steroidal saponin with anti-cancer effects on several types of …
Her-2 targeted therapy in advanced urothelial cancer: from monoclonal antibodies to antibody-drug conjugates
V Albarrán, DI Rosero, J Chamorro, J Pozas… - International Journal of …, 2022 - mdpi.com
Metastatic urothelial cancer, associated with a poor prognosis, is still major cause of cancer-
related death, with scarce options of effective treatment after progression to platinum-based …
related death, with scarce options of effective treatment after progression to platinum-based …